Catalent collaborates with Grid Therapeutics to develop novel therapy
Catalent Pharma Solutions announced it has signed a multi-year agreement with Grid Therapeutics, for the development and manufacture of Grid’s lead therapeutic candidate for the treatment of solid tumours